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Abstract
Background: Although useful for probing bacterial pathogenesis and physiology, current random mutagenesis systems
suffer limitations for studying the toxin-producing bacterium Clostridium perfringens.
Methodology/Principal Findings: An EZ-Tn5-based random mutagenesis approach was developed for use in C. perfringens.
This mutagenesis system identified a new regulatory locus controlling toxin production by strain 13, a C. perfringens type A
strain. The novel locus, encoding proteins with homology to the AgrB and AgrD components of the Agr quorum sensing
system of Staphylococcus aureus and two hypothetical proteins, was found to regulate early production of both alpha toxin
and perfringolysin O (PFO) by strain 13. PFO production by the strain 13 DagrB mutant could be restored by genetic
complementation or by physical complementation, i.e. by co-culture of the strain 13 DagrB mutant with a pfoA mutant of
either strain 13 or C. perfringens type C CN3685. A similar AgrB- and AgrD-encoding locus is identifiable in all sequenced C.
perfringens strains, including type B, C, D, and E isolates, suggesting this regulatory locus contributes to toxin regulation by
most C. perfringens strains. In strain 13, the agrB and agrD genes were found to be co-transcribed in an operon with two
upstream genes encoding hypothetical proteins.
Conclusions/Significance: The new Tn5-based random mutagenesis system developed in this study is more efficient and
random than previously reported C. perfringens random mutagenesis approaches. It allowed identification of a novel C.
perfringens toxin regulatory locus with homology to the Agr system of S. aureus and which functions as expected of an Agr-
like quorum sensing system. Since previous studies have shown that alpha toxin and perfringolysin O are responsible for
strain 13-induced clostridial myonecrosis in the mouse model, the new agr regulatory locus may have importance for strain
13 virulence.
Citation: Vidal JE, Chen J, Li J, McClane BA (2009) Use of an EZ-Tn5-Based Random Mutagenesis System to Identify a Novel Toxin Regulatory Locus in Clostridium
perfringens Strain 13. PLoS ONE 4(7): e6232. doi:10.1371/journal.pone.0006232
Editor: Adam J. Ratner, Columbia University, United States of America
Received April 6, 2009; Accepted June 15, 2009; Published July 14, 2009
Copyright:  2009 Vidal et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant R01 AI056177-06 from National Institute of Allergy and Infectious Diseases. JEV thanks a generous support from the
Mexican National Council of Science and Technology (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bamcc@pitt.edu
Introduction
Clostridium perfringens is a major pathogen of humans and other
animals, causing a spectrum of serious enteric and histotoxic
infections ranging from clostridial myonecrosis to Clostridium
perfringens type A food poisoning [1]. The virulence of this
Gram-positive, spore-forming anaerobe is largely attributable to
its prodigious toxin production, with the literature reporting at
least 17 different C. perfringens toxins [1]. However, toxin
production varies from strain-to-strain, allowing individual C.
perfringens isolates to be classified into types A–E, based upon their
production of four typing toxins (alpha, beta, iota and epsilon
toxins).
Besides being an important pathogen, C. perfringens is also
ubiquitously distributed in the environment [1]. This bacterium is
commonly found amongst the normal intestinal flora of most
animal species, including humans [1,2]. C. perfringens is also a
common inhabitant of soils, both in its spore and vegetative forms
[3]. Due to its presence in feces and ability to form resistant spores,
C. perfringens has been used as an indicator organism for fecal water
pollution [4].
C. perfringens is the most genetically tractable of all pathogenic
clostridial species. Using allelic exchange-based techniques, it has
been possible for .15 years to construct directed null mutants in
transformable strains of this bacterium [5]. More recently,
adaptation of group II introns (Targetrons) has greatly improved
the efficacy of directed C. perfringens mutant construction [5–7]. For
example, Targetron technology facilitated rapid construction of
several C. perfringens single and double toxin null mutants [6,8,9],
or mutants unable to express an acid soluble protein important for
spore resistance properties [10], providing new understanding of
C. perfringens virulence, pathogenesis and physiology.
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Despite these recent improvements in directed mutant con-
struction, there are still technical limits for performing genetics in
C. perfringens. For example, random mutagenesis is a powerful tool
for providing insights into bacterial gene function, but this
technique remains suboptimal for all pathogenic clostridial species,
including C. perfringens. While, Tn916 has been successfully used
for many years as a mutagenic tool for C. perfringens [11–13], this
transposon suffers from several significant limitations. One
problem is Tn916’s tendency towards multiple insertions, with
several studies detecting multiple Tn916 insertions in 65–75% of
all isolated C. perfringens mutants [12,13]. In addition, Tn916
remains active after integration, resulting in unstable mutants [14].
A final problem is that Tn916 insertion can be followed by a
deletion event that removes DNA regions, rather than inactivating
a specific gene [12].
Because of those Tn916 limitations, there is interest in
identifying alternative transposon tools for C. perfringens random
mutagenesis. To that purpose, another group recently reported
development of a phage Mu-based, random transposition
mutagenesis system for C. perfringens [15], which proved relatively
efficient and produced mutants with only a single transposon
insertion. Although not directly addressed in that study, C.
perfringens phage Mu-system mutants should also be stable based
upon results with other bacteria [16]. However, the new phage
Mu system still exhibited limitations when used in C. perfringens,
including, i) nearly half of all the obtained mutants carried their
transposon insertion in a rRNA gene [15] and ii) the number of C.
perfringens mutants obtained per mg of Erm-Mu transposase DNA
was relatively low, e.g., 239 transformant colonies/mg DNA for
strain JIR325 (a strain 13 derivative) [15].
EZ-Tn5 random mutagenesis (EpicentreH) is an alternative
approach to phage Mu-based systems for random mutagenesis.
The EZ-Tn5 system has allowed random mutagenesis in many
bacterial species (www.epibio.com) and retains the simplicity of
phage Mu-based mutagenesis. However the EZ-Tn5 system
possesses two important advantages, i) a high transposition
frequency (e.g., reportedly ,100-fold higher than phage Mu-
based systems) and ii) the highest degree of ‘‘randomness’’ for
insertions among commercially-available transposition systems,
including phage Mu (www.epibio.com).
Transformants carrying a EZ-Tn5 insertion are easily identifi-
able by antibiotic selection. However, commercial EZ-Tn5
transposons are sold with antibiotic resistance determinants that
either do not work in C. perfringens or would impart novel resistance
characteristics to this organism. Therefore, to explore the potential
usefulness of the EZ-Tn5 system for improving random mutagen-
esis in C. perfringens, we modified a commercial EZ-Tn5 pMOD
vector by inserting a C. perfringens erythromycin resistance
determinant (Fig. 1). This modified EZ-Tn5 transposon proved
highly useful for random mutagenesis of C. perfringens, identifying a
novel locus regulating the production of both a toxin and
perfringolysin O (PFO) in strain 13.
Results
Development of an EZ-Tn5-based random mutagenesis
system for C. perfringens
A transposome mixture (containing the erm-carrying transposon
DNA+EZ2Tn5 transposase) was electroporated into strain 13. A
total of ,280 erythromycin (Erm)-resistant transformants were
obtained in each of three independent transformation experiments
with strain 13. PCR reactions using primers erm-Fwd-EcoRI and
erm-Rev-HindIII confirmed that the erm gene, which is present in
the modified Tn5 transposon but is not naturally encoded by C.
perfringens strain 13, was carried by all strain 13 transformants
growing on BHI plates containing Erm (data not shown). Thus, for
strain 13, the efficiency of the erm-carrying EZ-Tn5 transposon
insertion was ,11,200 transformants/mg transposon DNA.
Random insertion of the erm-carrying transposon in C.
perfringens
Southern hybridization with an erm probe was used to assess the
‘‘randomness’’ of transposon insertion in the strain 13 mutants.
Only a single copy of the erm gene was detected in 8 different C.
perfringens strain 13 transposon mutants (Fig. 2). These Southern
blot analyses also suggested that the erm gene had apparently
inserted into different DNA regions in these mutants (Fig. 2). To
confirm that EZ-Tn5 insertions are random, upstream and
downstream regions flanking the transposon were sequenced for
11 arbitrarily selected C. perfringens strain 13 mutants. Table 1
results confirmed that the transposon insertions were random and
had occurred within ORF sequences, including ORFs encoding a
putative virulence factor (9%), hypothetical proteins (27%), genes
encoding proteins of metabolic pathways or protein biosynthesis
(45%) and rRNA genes (18%).
Disruption of the C. perfringens agrB gene using EZ-Tn5
transposon mutagenesis
To demonstrate the usefulness of the new EZ-Tn5 system, our
strain 13 mutant library was screened by growth on blood agar
plates or egg yolk agar plates for reduced or lost PFO-induced b-
hemolysis or CPA phospolipase activity, respectively. One EZ-
Tn5-carrying mutant, named CPJV501, exhibited a complete loss
of PFO-induced b-hemolysis halo when growing on blood agar
plates and a reduced phospholipase C (alpha toxin)-induced halo
when growing on egg yolk agar plates (data not shown). PCR
analyses, using primers shown in Table 2, indicated (data not
shown) that the transposon present in this mutant had not
disrupted either its pfoA gene (including its promoter and virR
Figure 1. Modification of the EZ-Tn5-encoding vector for
random mutagenesis in C. perfringens. To allow selection of C.
perfringens transformants after electroporation with the EZ-Tn5
transposon, a C. perfringens erythromycin resistance determinant
(erm) was cloned into the multiple cloning site in the Epicentre EZ-
TN5-encoding pMOD-2 vector creating pJVTN5. This plasmid also
contains PvuII-recognized sequences flanking the mosaic end (ME) sites,
which are specifically recognized by the EZ-Tn5 transposase.
doi:10.1371/journal.pone.0006232.g001
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boxes), the plc gene, or the virS/virR operon that had previously
been shown to regulate pfoA and plc transcription [11,17,18].
Therefore, the DNA flanking the erm-modified EZ-Tn5 transpo-
son in CPJV501 was sequenced, which revealed that the transposon
had inserted into strain 13 ORF CPE1561 (Table 1). Southern blot
analyses showed that this mutant carries only one copy of the
transposon integrated in its genome (Fig. 3A). PCR analysis using
primers that amplify the wt CPE1561 gene (642 bp) in strain 13
then further demonstrated the presence of the transposon-disrupted
CPE1561 gene (1600 bp) in CPJV501 (Fig. 3B).
A homolog of the putative protein encoded by the CPE1561
gene has been annotated as AgrB for C. perfringens strain ATCC
13124 [19], which is found in other Gram-positive bacteria,
including some other clostridial species. In S. aureus, AgrB and the
secreted peptide AgrD are part of a well-characterized quorum
sensing (QS) system that is involved in regulating the expression of
virulence genes, including several toxins [20]. Bioinformatics
analyses using the Pathema website further revealed that a
sequence with 100% homology to the agrB ORF in C. perfringens
strain 13 and ATCC 13124 is also present in all other sequenced
C. perfringens isolates, including those classifying as types A–E (data
not shown). Moreover, the region between ORFs CPE1561 and
CPE1560 in strain 13 contains a small (135 bp) ORF (Fig. 3C)
sharing ,99% homology with a putative agrD gene from C.
perfringens type A strain SM101 and ATCC13124 [21].
The C. perfringens agr locus regulates PFO production
Results presented above suggested that PFO production is
regulated by the C. perfringens agr locus. A hemoglobin release (Hb)
assay [22] was used to examine the kinetics of this regulation. In
this assay, the ability of C. perfringens supernatants to lyse horse
erythrocytes and release Hb is specifically attributable to PFO
activity [11], as further supported by our observation that the
culture supernatant of a C. perfringens strain 13 pfoA-null mutant is
incapable of inducing Hb release from horse erythrocytes (Fig. 4A).
Using this horse erythrocyte assay, the appearance of PFO activity
in the supernatant of CPJV501 was delayed by 2 h compared to wt
strain 13 (Fig. 4A and 4B). This difference was not due to growth
differences between CPJV501 and wt strain 13 (Fig. 4C). The absence
of PFO activity in the early growth phase supernatants of CPJV501
involved an inhibition of early pfoA transcription in CPJV501.
Specifically, quantitative RT-PCR analyses revealed that a 2 hour
CPJV501 culture contains ,700-fold less pfoA mRNA than does the
equivalent culture of wt strain 13 (Fig. 5A).
Co-culture with DpfoA strains can restore PFO
production by strain 13 agrB mutant
In S. aureus, AgrD is a secreted factor that activates the agr-mediated
regulatory network [23]. In the current study, we found that PFO
production by CPJV501 could be restored by coincubating CPJV501
with either a strain 13 pfoA-null mutant or a C. perfringens type C
CN3685 pfoA-null mutant, both of which retain an intact agr locus
(Fig. 6A and 6B). These physical complementation results suggested
that toxin regulation by the agr locus involves either cell to cell contact
or a secreted factor(s). To distinguish between those two possibilities,
CPJV501 and strain 13 pfoA-null mutant were inoculated into the
same 100 mm tissue culture dish but physically separated by a
Transwell filter. As shown in Fig. 6C, inoculation of the strain 13
Figure 2. Southern blot analyses of C. perfringens random mutants obtained after electroporation with EZ-Tn5 transposomes. After
selection on BHI plates containing Erm (40 mg/ml), DNA was extracted from strain 13 transformants. Following digestion with EcoRI (A) or XbaI (B), the
digested DNA was electrophoresed and blotted to a nylon membrane. DNA on the membranes was then hybridized with a Dig-labeled erm probe, as
found in the C. perfringens-modified EZ-Tn5, and blots were developed as described in the Materials and Methods. Size of DNA fragments, in kilobases
(kb), is shown at left.
doi:10.1371/journal.pone.0006232.g002
Table 1. Target gene of the EZ-Tn5 based transposon in C.
perfringens strain 13.
Mutant Gene name or locus tag, description
S13Tn5-01
(CPJV501)
CPE1561 (agrB), quorum sensing regulatory protein
S13Tn5-03 rrnB-16S (CPEr004), 16S ribosomal RNA,
S13Tn5-04 CPE2407, elongation factor Tu
S13Tn5-05 CPE1142, hypothetical protein
S13Tn5-06 16S RNAr
S13Tn5-07 CPE1892, 50S ribosomal protein L20
S13Tn5-09 CPE1736, ribulose phosphate 3-epimerase
S13Tn5-10 CPE0027, hypothetical protein
S13Tn5-11 CPE2524, methionyl-tRNA synthetase
S13Tn5-12 CPE0643, hypothetical protein
S13Tn5-13 CPE2348, phosphate butyryltransferase
doi:10.1371/journal.pone.0006232.t001
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pfoA-null mutant into the top well of the dish, and CPJV501 into the
bottom well of the dish, restored PFO activity to similar levels as
shown by the wt strain 13, i.e. this physical complementation involves
a secreted factor produced by both strain 13 and CN3685.
The C. perfringens agr locus also regulates CPA
production
Relative to wt strain 13, production of CPA in culture
supernatants was also reduced in 2 h cultures of CPJV501, as
detected by an ELISA assay (Fig. 7A). Western blot analyses of
bacterial lysates demonstrated that this reduction of CPA
supernatant levels was due to decreased intracellular production
of CPA by CPJV501, rather than impaired CPA secretion
(Fig. 7B). qRT-PCR analyses demonstrated that this reduced
CPA production involved transcriptional regulation; compared to
wt strain 13, levels of cpa mRNA were reduced about 7-fold in
2 hour cultures of this agrB mutant (Fig. 5B). Together, these
results indicated that the agr locus is involved in regulating pfoA
and cpa transcription, and thus PFO and CPA production, during
the early logarithmic growth phase.
Evidence that C. perfringens agrB and agrD gens are co-
transcribed in an operon
In S. aureus, the agr locus is encoded by an operon consisting of
four genes, agrB, agrD, agrC, and agrA [23–25]. The agrA and agrC
genes encode a response regulator and histidine kinase, respec-
tively, of a two-component regulatory system (TCRS). This TCRS
responds to a small peptide named an autoinducer (AI), which is
encoded by the agrD gene. The agrB gene encodes the enzyme
cleaving and modifying the AI [24].
To confirm that the C. perfringens agr locus contributes to early
regulation of PFO and CPA expression in strain 13, and to assess
whether agrB and agrD are expressed by C. perfringens as part of an
operon, the agrB gene alone, the agrB and agrD genes alone, or the
agrB, agrD and two ORFs (CPE1563 and CPE1562, which are
annotated as encoding hypothetical proteins) that lie upstream of
agrB were cloned into the E. coli-C. perfringens shuttle vector
pJIR750, creating the plasmids P1, P2 or P3 respectively (Fig. 3C).
Those plasmids were then individually electroporated into
CPJV501 to create the strains CPJVp1, CPJVp2 or CPJVp3.
PCR analyses confirmed the genotype of these CPJV501
complementing strains (Fig. 3B).
Neither CPJVp1 (encoding agrB alone) nor CPJVp2 (encoding
agrB and agrD) were able to restore PFO or CPA production
(Figs. 4B and 7A). However, complementation with CPJVp3
(encoding CPE1563, CPE1562, agrB and agrD) did restore 2 h
supernatant PFO activity and CPA levels to approximately those
found in culture supernatants of the wt strain 13 (Figs. 4B and 7A).
qRT-PCR analyses confirmed that 2 h cultures of CPJVp3
exhibited similar levels of pfoA and cpa mRNA as found in 2 h
cultures of the wt strain 13 (Fig. 5). In contrast, CPJVp1 and
Table 2. Primers used in this study.
Primer Sequence Reference
erm-Fwd-EcoRI AAGGGAATTCCTAAAAATTTGTAATTAAGAAGGAGT This study
erm-Rev-HindIII AAGGAAGCTTCCAAATTTACAAAAGCGACTCATA
pMOD-SeqFwd GCCAACGACTACGCACTAGCCAAC Epicentre
pMOD-SeqRev GAGCCAATATGCGAGAACACCCGAGAA
agrBFwd GATTGAGAATATATCGAAGTTAAT This study
agrBRev TATGTAGGTTAGAGTCATACATTGC
agrBF TTACGAATTCGATGTTAGCCATGTATGCTTTCG This study
agrBR TAGAGGATCCTCATTTAACTCATCCCCTCAAG
agrF1 TTACGAATTCTTAGCTCTTTATATTGGATATACAG This study
agrR1 TAGAGGATCCCCGGTTTAAAACCGACCTTTAG
pfoAF1 ATCCAACCTATGGAAAAGTTTCTGG [22]
pfoAR1 CCTCCTAAAACTACTGCTGTGAAGG
cpaF GCTAATGTTACTGCCGTTGA [45]
cpaR CCTCTGATACATCGTGTAAG
polCJVL AATATATGATACTGAAGAGAGAGTAA This study
polCJVR TCTAAATTATCTAAATCTATGTCTACT
agr101L TAAATTTGCTCCAGTAGATACTAA This study
agrDR TATTCATCTCTTAAAGATTTTGGT
agr102L TTCAAGTTTGATATTGGTATTAGT This study
agr101R CAAAGCTTCTAAAGCTATATTAAA
agr103L ATGATAGGAACAAGTACAGTAAAA This study
agr102R AACTTGAAATTAAATATTCCTTCT
agr104L AAATTTAAAACTTGTTATTGGAGT This study
agr103R GGCTTTAAACTATATCCTTTTATT
pfoA81L CCCAGTTATTCACGATTAAAG This study
pfoA82R AGTAATACTAGATCCAGGGTATAAA
doi:10.1371/journal.pone.0006232.t002
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CPJVp2 exhibited substantially less, if any, complementation in
these qRT-PCR analyses.
Results presented above suggested that agrB and agrD may be
transcribed as an operon that also includes the two upstream
ORFs CPE1563 and CPE1562, which are annotated as encoding
hypothetical proteins (Fig. 8). To assess further whether agrB and
agrD might be transcribed as part of an operon, RT-PCR analyses
were performed using RNA extracted form the wt strain 13. These
RT-PCR analyses also used primers that would produce a product
only if every two ORF’s from CPE1564 through agrD are co-
transcribed. Fig. 8 results showed evidence for significant levels of
co-transcription of CPE1563 and CPE1562, CPE1562 and agrB
(CPE1561), and agrB and agrD, strongly suggesting that all four of
these genes are co-transcribed in an operon. Interestingly, mRNA
transcript was also detected for CPE1564 and CPE1563, but the
signal was less intense than for the other transcripts, possibly
suggesting a weak promoter can also independently co-transcribe
these two ORFs.
Discussion
This study reports the development of a simple EZ-Tn5-based
approach for random mutagenesis in Clostridium perfringens. All
screened EZ-Tn5 mutants obtained by this method contained only
a single transposon insertion and were stable over at least 10
sequential overnight culturings. This new approach produced
mutants at high efficiency, i.e., 11,200 CFU/mg DNA for strain
13. This mutant yield was 46-fold higher than recently reported
for phage Mu-based random mutagenesis of a C. perfringens strain
13 derivative [15], which is consistent with previous reports
comparing mutant yields for other bacteria when using EZ-Tn5
vs. phage Mu-based random mutagenesis approaches (www.
epibio.com).
Besides better efficiency, EZ-Tn5 random mutagenesis possesses
a second advantage over the phage Mu-based system. When
applied to C. perfringens, phage Mu-based transpositions favored
insertion into rRNA genes, with nearly 45% of the phage Mu-
Figure 3. Generation of a C. perfringens agrB mutant and complementing strains. A) Southern blot analyses, as described in Fig. 2, using
EcoRI-digested DNA from CPJV501 and a Dig-labeled probe that detected a single copy of the erm gene. Size of DNA fragments, in kilobases (kb) is
shown at left. B) PCR was performed with DNA extracted from the indicated strain and the following pair of primers, agrBFwd and agrBRev in
reactions containing DNA from strain 13 (S13), CPJV501 and CPJVp1; agrBFwd and argDR for CPJVp2 and agrF1 and agrD100R for CPJVp3. DNA
ladders (100 bp or 1 kb) were included in the first and last lane of the gel. Asterisks show the expected PCR product when the primers amplified the
Tn5-disprupted agrB gene. C) Genes cloned in the E. coli-C. perfringens shuttle plasmid pJIR750 to complement the agrB transposon mutant. As
shown, P1 encodes the agrB gene alone, P2 the agrB and agrD genes and P3 encodes two-genes (CPE1562 and CPE1563) upstream the agrB gene
(CPE1561) and agrB and agrD.
doi:10.1371/journal.pone.0006232.g003
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Figure 4. The C. perfringens agrB locus regulates PFO production. A and B) Hemoglobin (Hb) release assay. Culture supernatants obtained, at
the indicated time point, from strain 13 (S13), S13 pfoA-null mutant (S13DpfoA), CPJV501 (DagrB), CPJVp1 (DagrB/P1), CPJVp2 (DagrB/P2) or CPJVp3
(DagrB/P3), were incubated (1:1) with a 1% suspension of horse red blood cells for 30 min at 37uC. Non-inoculated TGY or 0.1% saponin (Saponin)
was included as negative or positive control, respectively. PFO-induced Hb release was detected by obtaining the absorbance at 570 (A570). C) For
each time point, the OD600 of the cultures is shown. For all panels, error bars represent the standard error of the mean calculated using data from
three independent experiments.
doi:10.1371/journal.pone.0006232.g004
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based C. perfringens mutants carrying an insertion into a rRNA gene
[15]. Since another 12% of those phage Mu-based mutants carried
an insertion into an intergenic region, only ,45% of the C.
perfringens mutants in that phage Mu-based library had the desired
outcome, i.e., a transposon insertion into a protein-encoding ORF.
While the EZ-Tn5 transposon exhibited somewhat higher
insertion rates into C. perfringens rRNA genes than would be
expected by mere chance, this preference was much less than
observed for phage Mu-based random mutagenesis. Specifically,
only 18% of the screened EZ-Tn5 C. perfringens mutants carried a
transposon insertion into a rRNA gene (rRNA genes represent
about 1.5% of total genes in C. perfringens). Since none of the EZ-
Tn5 C. perfringens strain 13 mutants happened to carry a
transposon insertion in an intergenic region (although limited
intergenic EZ-Tn5 insertion was observed with another C.
perfringens strain, data not shown), ,73% of the transposons in
the screened C. perfringens strain 13 EZ-Tn5 carrying mutants had
single insertions in a protein encoding gene.
The current study then directly demonstrated the utility of the
new EZ-Tn5 random mutagenesis system by identifying a new
locus involved in controlling early log-phase production of a toxin
and PFO by C. perfringens strain 13. Prior to the current work,
regulation of PFO and a toxin expression in strain 13 was known
to involve a classical bacterial two component regulatory system
named VirS/VirR, where VirS is the membrane sensor and VirR
is the transcriptional regulator [11,17,18,26–30]. When phosphor-
ylated, the VirR protein binds directly to VirR boxes located
upstream of the pfoA gene encoding PFO. However, VirR boxes
are not present upstream of the plc gene encoding a toxin [31–34];
instead, a regulatory RNA (named VR-RNA), whose transcription
is itself regulated by VirS/VirR, is involved in control of a toxin
expression [28]. In addition, previous studies have implicated the
LuxS quorum sensing system in the regulation of a toxin and PFO
expression by strain 13 [35].
The current study reveals a new level of complexity in the
regulation of a toxin and PFO expression by strain 13.
Specifically, the current results demonstrated that the early log-
phase regulation of a toxin and PFO expression by this C.
perfringens strain involves a locus containing ORFs with homology
to S. aureus agrB and agrD. A recent bioinformatics search had
identified the presence of agr ORFs in many firmicutes, including
C. perfringens [21], but it had not yet been evaluated whether this
system is functional or important for regulating C. perfringens
virulence factor expression. As mentioned in the Results, a similar
agr locus is well-established in quorum sensing regulation of S.
aureus virulence, where the agr locus controls expression of several
toxins, as well as some surface virulence factors [20]. A similar agr
locus was also recently implicated in Listeria monocytogenes virulence,
where agrD-dependent quorum sensing regulates biofilm forma-
tion, Caco-2 cell invasion and mouse virulence [36].
In S. aureus, the agr locus is a four gene operon transcribed
primarily from a promoter named P2 [20]. This S. aureus agr
operon encodes for a TCRS (that includes the AgrA transcrip-
tional regulator and the AgrC membrane sensor), the agrD
signaling peptide, and an AgrB transmembrane protein involved
in AgrD processing. Once activated and secreted, extracellular
AgrD binds to (and activates) AgrC, which then phosphorylates
AgrA. The phosphorylated AgrA then binds to P2 and to another
promoter named P3 [25,37]. This P3 binding leads to production
of a regulatory RNA (named RNAIII) encoded by a gene adjacent
to the agr locus. RNAIII then modulates expression of several
exotoxins and surface proteins.
The agr systems of C. perfringens and S. aureus apparently share
some similarities. Our results clearly demonstrated that, as in S.
Figure 5. Early transcription of pfoA and plc genes is regulated by the C. perfringens agr locus. Total RNA was extracted from a 2 h TGY
culture of the wt strain 13 (S13), CPJV501 (DagrB), CPJVp1, CPJVp2 or CPJVp3. Quantitative RT-PCR was then performed with 20 ng of each RNA and
primers that amplified the (A) pfoA gen (pfoAF1 and pfoAR1) or the (B) plc gene (cpaF and cpaR). Average CT values were normalized to the polC gene
and the fold differences were calculated using the comparative CT method (2
2DDC
T) [44]. Values below each bar indicate the calculated fold change
relative to the wt strain 13. Panels shown are representative of three independent experiments.
doi:10.1371/journal.pone.0006232.g005
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Figure 6. A C. perfringens secreted factor(s) regulates PFO production. A and B) Physical complementation of the DagrB mutant by co-culture
with a DpfoA mutant of strain 13 or CN3685. C. perfringens strain 13 (S13), CPJV501 (DagrB), S13 pfoA-null mutant (S13DpfoA), CPJV501 and S13 pfoA-
null mutant (DagrB/S13DpfoA) or CPJV501 and CN3685 pfoA-null mutant (DagrB/CN3685DpfoA) were inoculated in TGY and incubated at 37uC for
the indicated time. Culture supernatants obtained, at the indicated time point, were incubated (1:1) with a 1% suspension of horse red blood cells for
30 min at 37uC. Non-inoculated TGY or 0.1% saponin was included as negative or positive control, respectively (not shown). PFO-induced Hb release
was detected by obtaining the absorbance at 570 nm (A570). C) The physical complementation shown in panels A and B requires a secreted factor to
regulate PFO production. Strain 13 (S13), CPJV501 (DagrB) or S13 pfoA-null mutant (DpfoA) was inoculated in 100 mm tissue culture dishes
containing 25 ml of TGY. Another 100 mm tissue culture dish containing a transwell filter device (0.4 mm pore size) received 25 ml of TGY. Then, the
S13 pfoA-null mutant was inoculated into the top chamber and CPJV501 was inoculated into the bottom chamber of the dish (bottom DagrB/Top
S13DpfoA) and incubated for the indicated time. Culture supernatants obtained at the indicated time points were incubated (1:1) with a 1%
suspension of horse red blood cells for 30 min at 37uC. PFO-induced Hb release was detected by obtaining the absorbance at 570 nm (A570). For all
panels, error bars represent the standard error of the mean calculated using data from three independent experiments.
doi:10.1371/journal.pone.0006232.g006
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aureus, the agr locus (via a secreted factor) transcriptionally regulates
toxin production by C. perfringens strain 13. Since the agr locus is
involved in controlling early log-phase expression of a-toxin and
PFO and these two toxins are important for C. perfringens-induced
gas gangrene [12,38,39], the agr locus may play an important role
in C. perfringens virulence, although this needs to be experimentally
confirmed. Another similarity, revealed by our RT-PCR and
complementation results, is that both C. perfringens and S. aureus co-
transcribe agrB and agrD as part of an operon.
There also appear to be some differences between the agr
systems of S. aureus versus C. perfringens. One variation concerns the
arrangement of the agrB and agrD genes within the agr operon. In
S. aureus, agrB and agrD are the first two transcribed genes in the
operon [20,25], but in C. perfringens these two agr genes appear to
be downstream of other genes in the operon. It is unclear whether
the two ORFs adjacent to agrB and agrD in C. perfringens encode a
TCRS, as in S. aureus, although those two ORFs co-transcribed
with agrB and agrD in the C. perfringens agr operon are currently
annotated as encoding ‘‘hypothetical proteins’’ and thus do not
possess obvious characteristics of a TCRS. However, future studies
should evaluate this possibility. A final difference between the agr
systems of C. perfringens versus S. aureus is that the RNAIII-encoding
gene lies in close proximity to the agr operon in S. aureus [25], but
no readily identifiable homolog of the RNAIII-encoding gene is
located near the C. perfringens agr operon or is readily identifiable
elsewhere in the strain 13 genome.
If the two upstream ORFs co-transcribed with the agrB and agrD
genes in C. perfringens do not encode a TCRS, sorting out the
signaling cascade may require some effort. The strain 13 genome
contains 28 known or putative histidine kinase sensors [40], which
coupled with one or more of the 20 known or putative response
regulators, could mediate AgrD signaling. Whether the C. perfringens
agr locus acts via the VirS/VirR TCRS, which is known to regulate
a toxin and PFO production, should be assessed. If C. perfringens
resembles S. aureus by using its Agr system to upregulate the
production of a regulatory RNA, that regulatory RNA should be
identified. A previous study [28] identified a C. perfringens regulatory
RNA named VR-RNA that is involved in strain 13 production of a
toxin. However, VR-RNA alone would not appear to readily
explain agr-mediated signaling since, this regulatory RNA is not
known to control PFO production [28], yet our agrBmutant cannot
produce PFO during early log-phase growth. Therefore, further
studies might evaluate whether several other putative regulatory
RNAs of C. perfringens [18] mediate the agr locus signal. Also, sorting
Figure 7. The C. perfringens agrB locus regulates CPA production. A) ELISA analyses. Culture supernatants obtained, at the indicated time
point, from strain 13 (S13), CPJV501 (DagrB), CPJVp1 (DagrB/P1), CPJVp2 (DagrB/P2), CPJVp3 (DagrB/P3) or purified CPA was used to coat a 96-well
microplate overnight at 4uC. The wells were incubated with a mouse monoclonal anti-CPA antibody followed by a HRP-conjugated anti-mouse
antibody. The bound antibody was detected with a TMB substrate solution and the color reaction stopped with sulphuric acid (0.18 M). A450 was
determined using an ELISA reader. Error bars represent the standard error of the mean calculated using data from three independent experiments. B)
Western blot showing the agr locus regulates production of CPA. Strain 13 (S13), CPJV501 (DagrB) or CPJVp3 (DagrB/P3) was inoculated in TGY and
incubated at 37uC for 4 h. Bacteria were then pelleted by centrifugation, resuspended in lysis buffer and sonicated. Equal amount (25 ml) of bacterial
lysates was run in a 12% SDS-PAGE, transferred to nitrocellulose membrane and western blotted with a monoclonal anti-CPA antibody. As a control,
25 ml of CPA-containing concentrated supernatant proteins was added to the gel. The expected molecular weight in kDa of CPA is shown at the left.
Shown is a representative figure of three independent experiments.
doi:10.1371/journal.pone.0006232.g007
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out the hierarchy of toxin expression control between the agr locus,
LuxS and the VirS/VirR TCRS will require further studies to fully
understand how C. perfringens regulates production of its toxins.
Additionally, future studies should also examine whether expression
of other toxins produced by some C. perfringens strains are regulated
by the Agr system. Finally, it would be interesting to identify the
environmental cues that signal the onset of agr operon transcription
in C. perfringens. While many additional studies are clearly needed to
fully understand it roles in C. perfringens, linkage of the agr locus to
PFO and a toxin production opens a new chapter towards
understanding toxin gene regulation by the important pathogen
C. perfringens.
Materials and Methods
Strains and bacterial culture media
Strain 13, a genome-sequenced, highly transformable C.
perfringens type A strain [40] was used for transposon mutagenesis
experiments. A strain 13 pfoA-null mutant and CN3685 pfoA-null
mutant were constructed using our previously described Targe-
tronH technology [6,8]. The bacterial culture media used
throughout this study included FTG (fluid thioglycolate medium;
Difco Laboratories), TGY (3% tryptic soy broth [Becton-
Dickinson]; 2% glucose [Sigma Aldrich], 1% yeast extract
[Becton-Dickinson], 0.1% sodium thioglycolate [Sigma Aldrich]),
TSC agar medium (SFP agar [Difco Laboratories], supplemented
with 0.04% of D-cycloserine [Sigma Aldrich]), Luria-Bertani (LB)
broth (1% tryptone [Becton-Dickinson], 0.5% yeast extract, 1%
NaCl), LB agar (1.5% agar [Becton-Dickinson]) and brain heart
infusion (BHI) agar (Becton-Dickinson). E. coli Top10 cells
(Invitrogen) were used as the cloning host. When indicated,
ampicillin (Amp, 100 mg/ml), erythromycin (Erm [100 mg/ml] or
[40 mg/ml]) or chloramphenicol (Cm [15 mg/ml]) was added to
the culture medium.
Construction of the modified EZ-Tn5 transposon vector
and transposome preparation
To modify the EZ-Tn5-carrying plasmid pMOD-2 (Epicentre)
for use in C. perfringens, a single colony of an E. coli strain encoding
the EZ-Tn5 pMOD-2 vector was inoculated into 10 ml of LB
broth supplemented with ampicillin (LBA) and then incubated
overnight at 37uC with shaking (250 RPM). The plasmid was
extracted with a QIAprep Spin plasmid extraction kit (Qiagen)
and simultaneously digested with EcoRI and HindIII (New
England Biolabs). The erythromycin resistance gene (erm) from
the E. coli-C. perfringens shuttle vector pJIR751 [41] was amplified
by PCR using JumpStart REDTaq ready mix (Sigma-Aldrich) and
primers erm-Fwd-EcoRI and erm-Rev-HindIII (Table 2). The
PCR product was run on a 1.5% agarose gel, purified using a
QIAquick gel extraction kit (Qiagen), and then simultaneously
digested with EcoRI and HindIII. The digested EZ-Tn5-carrying
pMOD-2 plasmid and the erm gene PCR product were ligated
overnight at 4uC with T4 DNA ligase (New England Biolab). The
resulting plasmid, named pJVTN5, was then transformed into
chemically competent E. coli Top10 cells (Invitrogen) and
inoculated onto LB agar plates supplemented with erythromycin
and ampicillin. To prepare the transposome, pJVTN5 was
digested with PvuII at 37uC for 1 h (see Fig. 1). The erm-carrying
Figure 8. Organization and RT-PCR analysis of the agr operon. A) RT-PCR reactions were performed with 50 ng of RNA extracted from an
overnight TGY culture of the wt strain 13. RT-PCR reactions included (+) or not (2) retrotranscriptase (RT). The following pair of primers were used to
detect mRNA transcripts from every two-adjacent ORF’s, agr104L and agr103R (L4-R3, which should generate a 321 bp PCR product), agr103L and
agr102R (L3-R2, which should generate a 315 bp PCR product), agr102L and agr101R (L2-R1, which should generate a 420 bp PCR product) or
agr101L and agrDR (B–D, which should generate a 520 bp PCR product). A 100-bp DNA ladder is shown at left. B) Schematic representation of the agr
locus showing primers used for RT-PCR reactions.
doi:10.1371/journal.pone.0006232.g008
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EZ-Tn5 transposon fragment (,900 bp) was purified from an
agarose gel as described earlier and DNA concentration was
quantified. Two ml of the erm-modified EZ-Tn5 Transposon DNA
(100 mg/ml in TE Buffer [10 mM Tris-HCl (pH 7.5), 1 mM
EDTA]) were mixed with 4 ml of the EZ-Tn5 transposase
(Epicentre) and 2 ml of glycerol. The mixture was incubated for
30 min at room temperature, to allow the transposase to stably
bind to the erm-modified EZ-Tn5 Transposon DNA; that mixture
was then stored at 220uC.
Transposome electroporation into C. perfringens strains
Following a standard procedure [6,42], 1 ml of the transposome
was electroporated into a 4 hour TGY culture of highly
transformable C. perfringens strain 13 [40]. For this purpose,
electrocompetent cells (400 ml) were mixed, in a 0.2 cm electro-
poration cuvette (Biorad), with 1 ml of the transposome and
incubated 5 min at 4uC. Electroporation was performed using a
BioRad Gene PulserTM with pulse controller set at 200V, 25 mF
and 1.5 kV. Electroporated transposome-containing bacteria were
grown in 3 ml of pre-warmed TGY for 3 h at 37uC to allow them
complete recovery, plated onto BHI agar plates with erythromycin
(40 mg/ml), and incubated at 37uC for 18 h under anaerobic
conditions. All colonies were propagated in BHI agar plates with
erythromycin (40 mg/ml). To confirm the presence of the erm gene,
a PCR was performed with 2 ml of cell lysate as DNA template.
This PCR used primers erm-Fwd-EcoRI and erm-Rev-HindIII
and the following PCR conditions: 1 cycle of 95uC for 5 min, 35
cycles of 95uC for 30 s, 55uC for 45 s, and 68uC for 1 min; and a
single extension of 68uC for 10 min.
Sequencing of the EZ-Tn5 target gene in selected
mutants
After electroporation of the transposon, C. perfringens strain 13
Erm-resistant transformants, which were also erm-positive by PCR,
were randomly chosen for sequencing. Total DNA was extracted
and 1 mg of each DNA was mixed with 10 pmol of primers
pMOD-SeqFwd or pMOD-SeqRev (Epicentre) and sent for
sequencing at the University of Pittsburgh Genomics and
Proteomics Core Laboratory. C. perfringens sequences flanking the
erm-carrying transposon were determined using the nucleotide
BLAST program on the National Center for Biotechnology
Information (NCBI) web site and the J. Craig Venter Institute’s
Pathema website programs.
Complementation of the agrB mutant
DNA was isolated from strain 13 using a Master PureTM Gram
Positive DNA purification Kit (Epicentre). The primers agrBF and
agrBR (Table 2) were added (at a 5 mM final concentration) to a
PCR mixture containing 1 ml of purified DNA template and 25 ml
26Taq mixture (NEB). Those reaction mixtures, with a total
volume of 50 ml, were placed in a thermal cycler (Techne) and
subjected to the following amplification conditions: 1 cycle of 95uC
for 2 min, 35 cycles of 95uC for 30 s, 55uC for 40 s, and 68uC for
3 min, and a single extension of 68uC for 5 min. The PCR
products were cloned into a TOPO vector (Invitrogen) and
sequenced at the University of Pittsburgh Core Sequencing
Facility. Using EcoRI and BamHI, the insert was removed from
the TOPO vector and ligated into pJIR750, forming a plasmid
named P1 (which is 1072 bp and contains agrB and a 403 bp
upstream sequence). Using the same method, two other comple-
menting plasmids were created, including P2 (created using agrBF-
agrR1 primers and which has a 1230 bp insert containing agrB
and agrD, along with a 403 bp upstream sequence) and P3 (created
using agrF1-agrR1 and which has a 2893 bp insert containing
agrB, agrD and two upstream ORFs encoding hypothetical
proteins). Plasmids P1, P2 and P3 were separately introduced,
by our standard electroporation techniques, into the agrB mutant
of strain 13. Chloramphenicol (15 mg/ml) resistant transformants
were then selected. The resultant transformants were designated
CPJVp1, CPJVp2 and CPJVp3.
Southern blot analyses
C. perfringens DNA was isolated using the MasterPure gram-
positive DNA purification kit (Epicentre, Wisconsin). Each isolated
DNA sample (2.5 mg) was then digested overnight with EcoRI or
XbaI, according to the manufacturer’s (New England Biolabs)
instructions. The digested DNA samples were electrophoresed on
a conventional 1% agarose gel, and the separated DNA digestion
products were then transferred onto nylon membranes (Roche) for
hybridization with an erm-specific probe. After hybridization of the
erm probe, the Southern blots were developed using reagents from
the DIG DNA labeling and detection kit (Roche), according to the
manufacturer’s instruction.
Hemoglobin (Hb) release assay for PFO activity
C. perfringens strain 13 (S13), S13 pfoA-null mutant, CPJV501,
CPJVp1, CPJVp2, CPJVp3, or a combination of CPJV501 and S13
pfoA-null mutant (at a 1:1 ratio), or CPJV501 and CN3685 pfoA-null
mutant (at a 1:1 ratio), were inoculated into 10 ml of FTG and
grown overnight at 37uC. An aliquot (100 ml) of this overnight
culture was then inoculated into a test tube containing 10 ml of
sterile TGY (OD600,0.05) and grown for the indicated times. At
each time point, the OD600 of the culture was recorded. In other
experiments, 100 mm tissue culture dishes (Costar) containing
25 ml of TGY were inoculated (OD600,0.05) with strain 13 or
CPJV501 and incubated at 37uC for the indicated times. Another
experiment used a 100 mm tissue culture dish containing a
TranswellH filter (Costar) and 25 ml of TGY; strain 13 pfoA-null
mutant was inoculated into the top well of the dish and CPJV501
was inoculated into the bottom chamber of the culture dish (at a 2:1
ratio). This culture was also incubated at 37uC for different times.
The culture supernatant was obtained and filter sterilized using a
0.45 mm filter (Millipore). The Hb release assay was then performed
essentially as previously described [43].
ELISA
C. perfringens alpha toxin (1 mg/ml) purchased from Sigma
Aldrich, or culture supernatants, were analyzed by ELISA using
mouse monoclonal anti-CPA antibody (kindly provided by Dr.
Paul Hauer), as previously described [43].
Western blot
Strain 13 (S13), CPJV501 (DagrB) or CPJVp3 (DagrB/P3) was
inoculated in 10 ml of TGY and incubated at 37uC for 4 h.
Bacteria were then pelleted by centrifugation at 80006g at 4uC for
30 min. The bacterial pellet was resuspended in 500 ml of ice-cold
lysis buffer [40 mM Tris-HCl pH 7.5, 100 mM NaCl, 16
protease inhibitors (Roche), 1 mM DTT and 1% Triton X-100]
and then sonicated. Equal amounts (25 ml) of bacterial lysates were
run in a 12% SDS-PAGE and transferred to nitrocellulose
membranes. As control, 25 ml of 1006 ammonium sulfate
supernatant-concentrated proteins of an overnight culture of
strain 13 was also run in the gel. Those membranes were blocked
with PBS-Tween 20 (0.05% v/v) and non fat dry milk (5% wt/v)
for 1 h and then probed with a mouse monoclonal anti-CPA
antibody. Bound antibody was then detected after incubation with
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a horseradish peroxidase-conjugated secondary anti-species spe-
cific antibody and addition of Chemiluminescent Substrate
(Pierce).
RT-PCR and qRT-PCR
Total C. perfringens RNA was extracted from 2 ml of an
overnight TGY culture by the following procedure. After
centrifugation of that culture (10,0006g at 4uC), the pellet was
resuspended in 200 ml of acetate solution (20 mM sodium acetate
[pH 5], 1 mM EDTA, 0.5% sodium dodecyl sulfate [SDS, Bio-
Rad]). The suspension received 200 ml of saturated phenol (Fisher
scientific) and was thoroughly resuspended before incubation at
60uC in a water bath with vigorous shaking for 5 min. After
centrifugation (10,0006g at 4uC for 5 min), the nucleic acid-
containing supernatant received cold ethanol and that sample was
mixed well. The mixed sample was centrifuged (10,0006g at 4uC)
for 5 min to obtain the RNA pellet. This pellet was washed two
times with cold 70% ethanol and finally resuspended in 100 ml of
DNase-free, RNase-free water. All RNA samples were additionally
treated with 2 U of DNase I (Promega) at 37uC for 30 min. To
stop DNase I activity, DNase I inhibitor (Promega) was added to
the reaction tube. RNA was quantified by absorbance at 260 nm
and stored in 50 ml aliquots at 280uC.
RT-PCR reactions were then performed on those DNase-treated
RNA samples using the AccesQuick RT-PCR system (Promega).
Briefly, 50 ng of each RNA sample were reversed-transcribed to
cDNA at 45uC for 45 min and then used as template for PCR
reactions (denaturing at 94uC for 1 min, annealing at 55uC for
1 min and extension at 72uC for 1 min) with the gene-specific
primers. Control RT-PCR reactions were similarly performed,
except for the omission of reverse transcriptase.
Quantitative RT-PCR (qRT-PCR) was performed using the
iScript One-Step RT-PCR kit with SYBR Green (Bio-Rad) and
the iCycler thermal cycler with a 96-well reaction module (Bio-
Rad). qRT-PCR reactions were performed in triplicate with 20 ng
of total RNA, 500 nM concentration of each primer (Table 2) and
the following conditions; 1 cycle at 50uC for 30 min, 1 cycle at
95uC for 10 min and 40 cycles of 95uC for 15, 55uC for 1 min.
Melting curves were generated by a cycle of 95uC for 1 min, 55uC
for 1 min and 80 cycles of 55uC with 0.5uC increments. The
relative quantitation of mRNA expression was normalized to the
constitutive expression of the housekeeping polC gene and
calculated by the comparative CT (2
2DDCT) method [44].
Note added during revision
During preparation of the revised version of this paper, Ohtani
et al. (2009) published work also implicating the C. perfringens agr
locus in control of PFO and CPA production by strain 13 (Ohtani,
K., et al. J. Bacteriology. 2009. 191(12):3919–27).
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